Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1559 |  LEGN Legend Biotech Corporation - American Depositary Shares | 18.71 USD | -2.14% | -3.16% | -7.47% | -41.49% | 3.46 B USD | ||
| 1573 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 19.58 USD | -0.36% | -2.20% | -28.64% | -7.95% | 3.37 B USD | ||
| 1584 |  CELC Celcuity Inc. - Common Stock | 67.87 USD | +3.18% | -9.66% | -26.23% | +38.20% | 3.32 B USD | ||
| 1598 |  VKTX Viking Therapeutics, Inc. - Common Stock | 27.73 USD | -2.84% | -10.11% | -16.88% | -17.27% | 3.23 B USD | ||
| 1617 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 72.22 USD | -1.89% | -4.77% | -16.32% | +9.32% | 3.17 B USD | ||
| 1640 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.49 USD | +1.32% | -3.96% | +1.83% | +15.85% | 3.08 B USD | ||
| 1646 |  DYN Dyne Therapeutics, Inc. - Common Stock | 16.37 USD | +2.50% | +2.12% | -15.53% | -30.07% | 3.06 B USD | ||
| 1658 |  RCUS Arcus Biosciences, Inc. Common Stock | 23.82 USD | -2.89% | -6.33% | -17.15% | +57.85% | 3.03 B USD | ||
| 1660 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.20 USD | -0.84% | -4.56% | -18.81% | +101.93% | 3.03 B USD | ||
| 1670 |  DNLI Denali Therapeutics Inc. - Common Stock | 18.67 USD | -2.56% | -10.46% | -13.92% | +15.46% | 2.98 B USD | ||
| 1673 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 40.63 USD | -1.76% | -14.25% | -31.19% | +96.66% | 2.98 B USD | ||
| 1720 |  ZLAB Zai Lab Limited - American Depositary Shares | 24.81 USD | -1.98% | +0.69% | -2.13% | -7.04% | 2.79 B USD | ||
| 1738 |  PGEN Precigen, Inc. - Common Stock | 7.60 USD | +0.80% | -8.43% | +10.95% | +138.24% | 2.72 B USD | ||
| 1787 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.26 USD | -3.93% | -13.58% | -16.13% | -41.38% | 2.54 B USD | ||
| 1788 |  BEAM Beam Therapeutics Inc. - Common Stock | 24.60 USD | -0.69% | -1.60% | -7.69% | -9.39% | 2.54 B USD | ||
| 1797 |  LQDA Liquidia Corporation - Common Stock | 28.02 USD | +5.02% | +4.98% | -58.42% | +23.98% | 2.51 B USD | ||
| 1839 |  IRON Disc Medicine, Inc. - Common Stock | 60.77 USD | -0.67% | -5.87% | -20.61% | -13.53% | 2.33 B USD | ||
| 1843 |  ADMA ADMA Biologics Inc - Common Stock | 10.33 USD | +1.87% | +3.09% | +9.08% | -29.30% | 2.31 B USD | ||
| 1851 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.60 USD | +0.66% | -0.45% | -5.74% | +28.16% | 2.31 B USD | ||
| 1852 |  NRIX Nurix Therapeutics, Inc. - Common stock | 22.21 USD | -2.29% | -6.37% | -16.00% | +98.13% | 2.30 B USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |